Analyst View, Impact of Global Events - Research Report on Metabolix, Inc. and Lexicon Pharmaceuticals, Inc.
October 07 2011 - 9:00AM
Marketwired
Today, www.WorldStreetFundamentals.com released its industry report
highlighting Metabolix, Inc. (NASDAQ: MBLX) and Lexicon
Pharmaceuticals, Inc. (NASDAQ: LXRX). Full fundamental and
technical analysis is available at
www.WorldStreetFundamentals.com/Reports.php?id=MBLX+LXRX.
Short-term outlooks within US and global economies continue to
adjust downward, as US Treasury yields touched their lowest levels
in over 65 years. International Monetary Fund downgraded estimates
for US growth by 1.0% this year, down from 2.5%. 'Significant
downside risks' to the US economy were confirmed by the Federal
Reserve pressured by 'strains in global financial markets.'
As the US dollar trades above an eight-month high against the
Euro, it highlights a deepening of the Eurozone sovereign debt
crisis -- furthered by continued policy inaction from European
governments. We expect continued volatility until economic data
stabilizes and we see decisive policy action to deal with the
Eurozone debt crisis.
Our members are preparing for a turn in tides. Currently, the
Credit Suisse Risk Appetite Indicator is at a 30-year low. For the
past three occurrences, this level has acted as a leading indicator
of large stock market rallies 18 months following.
World Street Fundamentals has highlighted Metabolix, Inc. for
its current position within the basic materials industry.
Metabolix, Inc. is a bioscience company that develops and is in the
process of commercializing environmentally sustainable,
alternatives to petroleum-based plastics with chemicals and energy.
The Company has core capabilities in microbial genetics,
fermentation process engineering, chemical engineering, polymer
science, plant genetics and botanical science. The entire report on
Metabolix, Inc. (NASDAQ: MBLX) is available here:
www.WorldStreetFundamentals.com/Report.php?id=MBLX.
World Street has featured Lexicon Pharmaceuticals, Inc. for its
development within the healthcare industry. Lexicon
Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company
focused on the discovery and development of treatments for human
disease. The entire report on Lexicon Pharmaceuticals, Inc.
(NASDAQ: LXRX) is available here:
www.WorldStreetFundamentals.com/Report.php?id=LXRX.
About World Street World Street Fundamentals is an online portal
for professionals, investors and new-comers to the markets to find
in depth comprehensive research and research tools to help guide
you through the ever changing financial markets.
Contact: Adam Redford Email Contact
www.WorldStreetFundamentals.com
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024